11:43 am GlaxoSmithKline confirmed approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD – HedgeChatter

11:43 am GlaxoSmithKline confirmed approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD

21 Apr

11:43 am GlaxoSmithKline confirmed approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD

Bystocknews GSK, stock Comments Off

View todays social media effects on GSK

View the latest stocks trending across Twitter. Click to view dashboard

See who GlaxoSmithKline is hiring next, click here to view

Author